Food and Drug Administration on Friday announced the approval of pharmaceutical giant Novo Nordisk's Wegovy (semaglutide) injection for adults who either have obesity or are overweight and have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
They measure electrolytes, blood sugar, kidney markers, liver enzymes, cholesterol, and blood cell counts
This study further demonstrated that exendin-4 treatment additionally reduced the presence of key inflammatory molecules, including TNF-alpha, interleukin 1 beta (IL-1beta), and IL-6, in mice livers [46], providing evidence for potential GLP-1 treatment for inflammation related to steatohepatitis
Gavin Creels Legacy: Beyond Broadway While Gavin Creels battle with metastatic melanotic peripheral nerve sheath sarcoma ended in tragedy, his legacy as a performer and advocate will live on